Research progress of microglial surface receptors in perioperative neurocognitive disorders

Abstract

Perioperative neurocognitive disorder (PND) is a common complication in the perioperative period, which not only prolongs the hospitalization of patients, increases the cost of treatment, but even increases the postoperative mortality of patients, bringing a heavy burden to families and society. Mechanism exploration involves anesthesia and surgery that lead to microglial activation, promote the synthesis and secretion of inflammatory factors, cause an inflammatory cascade, aggravate nerve cell damage, and lead to cognitive dysfunction. It is believed that microglia-mediated neuroinflammatory responses play a vital role in the formation of PND. Microglia surface receptors are essential mediators for microglia to receive external stimuli, regulate microglial functional status, and carry out intercellular signal transmission. Various microglial surface receptors trigger neuroinflammation, damage neurons, and participate in the development and progression of PND by activating microglia. In this study, the roles of immunoglobulin receptors, chemokine receptors, purinergic receptors, and pattern recognition receptors in microglia surface receptors in PND were reviewed, to provide a reference for the mechanism research, prevention, and treatment of PND.

Keywords

cell surface receptors / microglia / neuroinflammatory / perioperative neurocognitive disorders

References

[1] Evered L, Silbert B, Knopman DS, et al. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Br J Anaesth. 2018;121(5):1005-1012.

[2] Vacas S, Canales C, Deiner SG, Cole DJ. Perioperative brain health in the older adult: a patient safety imperative. Anesth Analg. 2022;135(2):316-328.

[3] Boone MD, Sites B, von Recklinghausen FM, Mueller A, Taenzer AH, Shaefi S. Economic burden of postoperative neurocognitive disorders among US Medicare patients. JAMA Netw Open. 2020;3(7):e208931.

[4] Safavynia SA, Goldstein PA. The role of neuroinflammation in postoperative cognitive dysfunction: moving from hypothesis to treatment. Front Psychiatry. 2019;9:752.

[5] Zheng B, Lai R, Li J, Zuo Z. Critical role of P2X7 receptors in the neuroinflammation and cognitive dysfunction after surgery. Brain Behav Immun. 2017;61:365-374.

[6] Skvarc DR, Berk M, Byrne LK, et al. Post-operative cognitive dysfunction: an exploration of the inflammatory hypothesis and novel therapies. Neurosci Biobehav Rev. 2018;84:116-133.

[7] Li Z, Liu F, Ma H, et al. Age exacerbates surgery-induced cognitive impairment and neuroinflammation in Sprague–Dawley rats: the role of IL-4. Brain Res. 2017;1665:65-73.

[8] Zhang D, Li N, Wang Y, et al. Methane ameliorates post-operative cognitive dysfunction by inhibiting microglia NF-κB/MAPKs pathway and promoting IL-10 expression in aged mice. Int Immunopharmacol. 2019;71:52-60.

[9] Needham MJ, Webb CE, Bryden DC. Postoperative cognitive. dysfunction and dementia: what we need to know and do. Br J Anaesth. 2017;119:i115-i125.

[10] Luo A, Yan J, Tang X, Zhao Y, Zhou B, Li S. Postoperative cognitive dysfunction in the aged: the collision of neuroinflammaging with perioperative neuroinflammation. Inflammopharmacology. 2019;27(1):27-37.

[11] Fan W, Mai L, Zhu X, Huang F, He H. The role of microglia in perioperative neurocognitive disorders. Front Cell Neurosci. 2020;14:261.

[12] Bai Q, Xue M, Yong VW. Microglia and macrophage phenotypes in intracerebral haemorrhage injury: therapeutic opportunities. Brain. 2020;143(5):1297-1314.

[13] Willis EF, MacDonald KPA, Nguyen QH, et al. Repopulating microglia promote brain repair in an IL-6-dependent manner. Cell. 2020;180(5):833-846.

[14] Dubbelaar ML, Kracht L, Eggen BJL, Boddeke EWGM. The Kaleidoscope of microglial phenotypes. Front Immunol. 2018;9:1753.

[15] Wang T, Zhu H, Hou Y, et al. Galantamine reversed early postoperative cognitive deficit via alleviating inflammation and enhancing synaptic transmission in mouse hippocampus. Eur J Pharmacol. 2019;846:63-72.

[16] Wang HL, Ma RH, Fang H, Xue ZG, Liao QW. Impaired spatial learning memory after isoflurane anesthesia or appendectomy in aged mice is associated with microglia activation. J Cell Death. 2015;8:9-19.

[17] Feng X, Valdearcos M, Uchida Y, Lutrin D, Maze M, Koliwad SK. Microglia mediate postoperative hippocampal inflammation and cognitive decline in mice. JCI Insight. 2017;2(7):e91229.

[18] Jiang J, Lv X, Liang B, Jiang H. Circulating TNF-αlevels increased and correlated negatively with IGF-I in postoperative cognitive dysfunction. Neurol Sci. 2017;38(8):1391-1392.

[19] Cheon SY, Kim JM, Kam EH, et al. Cell-penetrating interactomic inhibition of nuclear factor-kappa B in a mouse model of postoperative cognitive dysfunction. Sci Rep. 2017;7(1):13482.

[20] Suenaga J, Hu X, Pu H, et al. White matter injury and microglia/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke. Exp Neurol. 2015;272:109-119.

[21] Subramaniyan S, Terrando N. Neuroinflammation and perioperative neurocognitive disorders. Anesth Analg. 2019;128(4):781-788.

[22] Jiang W, Liu F, Li H, et al. TREM2 ameliorates anesthesia and surgery-induced cognitive impairment by regulating mitophagy and NLRP3 inflammasome in aged C57/BL6 mice. Neurotoxicology. 2022;90:216-227.

[23] Han X, Cheng X, Xu J, et al. Activation of TREM2 attenuates neuroinflammation via PI3K/Akt signaling pathway to improve postoperative cognitive dysfunction in mice. Neuropharmacology. 2022;219:109231.

[24] Niu W, Ma L, Tao T, et al. Surgery-induced cognitive dysfunction is alleviated through triggering receptor expressed on myeloid cells 2. Acta Histochem. 2020;122(5):151553.

[25] Lyons A, Minogue AM, Jones RS, et al. Analysis of the impact of CD200 on phagocytosis. Mol Neurobiol. 2017;54:5730-5739.

[26] Cox FF, Carney D, Miller AM, Lynch MA. CD200 fusion protein decreases microglial activation in the hippocampus of aged rats. Brain Behav Immun. 2012;26:789-796.

[27] Cao XZ, Ma H, Wang JK, et al. Postoperative cognitive deficits and neuroinflammation in the hippocampus triggered by surgical trauma are exacerbated in aged rats. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1426-1432.

[28] Xie X, Luo X, Liu N, et al. Monocytes, microglia, and CD200-CD200R1 signaling are essential in the transmission of inflammation from the periphery to the central nervous system. J Neurochem. 2017;141:222-235.

[29] Manich G, Recasens M, Valente T, Almolda B, González B, Castellano B. Role of the CD200-CD200R axis during homeostasis and neuroinflammation. Neuroscience. 2019;405:118-136.

[30] Ojo B, Rezaie P, Gabbott PL, et al. Age-related changes in the hippocampus (loss of synaptophysin and glial-synaptic interaction) are modified by systemic treatment with an NCAM-derived peptide, FGL. Brain Behav Immun. 2012;26:778-788.

[31] Ma D, Liu J, Wei C, et al. Activation of CD200-CD200R1 axis attenuates perioperative neurocognitive disorder through inhibition of neuroinflammation in mice. Neurochem Res. 2021;46(12):3190-3199.

[32] Lin F, Shan W, Zheng Y, Pan L, Zuo Z. Toll-like receptor 2 activation and up-regulation by high mobility group box-1 contribute to post-operative neuroinflammation and cognitive dysfunction in mice. J Neurochem. 2021;158(2):328-341.

[33] Zhang Y, Liu H, Chen Z, et al. TLR4-mediated hippocampal MMP/TIMP imbalance contributes to the aggravation of perioperative neurocognitive disorder in db/db mice. Neurochem Int. 2020;140:104818.

[34] Ray R, Juranek JK, Rai V. RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis. Neurosci Biobehav Rev. 2016;62:48-55.

[35] Zhang S, Hu L, Jiang J, et al. HMGB1/RAGE axis mediates stress-induced RVLM neuroinflammation in mice via impairing mitophagy flux in microglia. J Neuroinflammation. 2020;17(1):15.

[36] He HJ, Wang Y, Le Y, et al. Surgery upregulates high mobility group Box-1 and disrupts the blood–brain barrier causing cognitive dysfunction in aged rats. CNS Neurosci Ther. 2012;18(12):994-1002.

[37] Zhou H, Luo T, Wei C, Shen W, Li R, Wu A. RAGE antagonism by FPS-ZM1 attenuates postoperative cognitive dysfunction through inhibition of neuroinflammation in mice. Mol Med Rep. 2017;16(4):4187-4194.

[38] Rabinovich GA, Toscano MA. Turning ‘sweet’on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol. 2009;9:338-352.

[39] Li Y, Chen N, Wu C, et al. Galectin-1 attenuates neurodegeneration in Parkinson’s disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain. Brain Behav Immun. 2020;83:214-225.

[40] Park L, Wang G, Zhou P, et al. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-β. Proc Natl Acad Sci USA. 2011;108(12):5063-5068.

[41] Haskó G, Pacher P. Regulation of macrophage function by adenosine. Arterioscler Thromb Vasc Biol. 2012;32:865-869.

[42] Chen ZH, Han YY, Shang YJ, et al. Cordycepin ameliorates synaptic dysfunction and dendrite morphology damage of hippocampal CA1 via A1R in cerebral ischemia. Front Cell Neurosci. 2021;15:783478.

[43] Zhang Y, Cao H, Qiu X, et al. Neuroprotective effects of adenosine A1 receptor signaling on cognitive impairment induced by chronic intermittent hypoxia in mice. Front Cell Neurosci. 2020;14:202.

[44] Ko IG, Kim SE, Jin JJ, et al. Combination therapy with polydeoxyribonucleotide and proton pump inhibitor enhances therapeutic effectiveness for gastric ulcer in rats. Life Sci. 2018;203:12-19.

[45] Mizuno Y, Kondo T. Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson’s disease: study of istradefylline in PD. Mov Disorders. 2013;28(8):1138-1141.

[46] Colino-Oliveira M, Rombo DM, Dias RB, Ribeiro JA, Sebastião AM. BDNF-induced presynaptic facilitation of GABAergic transmission in the hippocampus of young adults is dependent of TrkB and adenosine A2A receptors. Purinergic Signal. 2016;12:283-294.

[47] Jeong H, Chung JY, Ko IG, et al. Effect of polydeoxyribonucleotide on lipopolysaccharide and sevoflurane-induced postoperative cognitive dysfunction in human neuronal SH-SY5Y cells. Int Neurourol J. 2019;23:S93-S101.

[48] Ribeiro DE, Glaser T, Oliveira-Giacomelli Á, Ulrich H. Purinergic receptors in neurogenic processes. Brain Res Bull. 2019;151:3-11.

[49] Nguyen HM, di Lucente J, Chen YJ, et al. Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4-mediated calcium entry in microglia. GLIA. 2020;68(11):2377-2394.

[50] Duveau A, Bertin E, Boué-Grabot E. Implication of neuronal versus microglial P2X4 receptors in central nervous system disorders. Neurosci Bull. 2020;36(11):1327-1343.

[51] Verma R, Cronin CG, Hudobenko J, Venna VR, McCullough LD, Liang BT. Deletion of the P2X4 receptor is neuroprotective acutely, but induces a depressive phenotype during recovery from ischemic stroke. Brain Behav Immun. 2017;66:302-312.

[52] Jurga AM, Piotrowska A, Makuch W, Przewlocka B, Mika J. Blockade of P2X4 receptors inhibits neuropathic pain-related behavior by preventing MMP-9 activation and, consequently, pronociceptive interleukin release in a rat model. Front Pharmacol. 2017;8:48.

[53] Srivastava P, Cronin CG, Scranton VL, Jacobson KA, Liang BT, Verma R. Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke. Exp Neurol. 2020;329:113308.

[54] Yuan H, Lu B, Ji Y, et al. Role of P2X4/NLRP3 pathway-mediated neuroinflammation in perioperative neurocognitive disorders. Mediators Inflamm. 2022;2022:1-9.

[55] Briones TL, Woods J, Wadowska M. Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling. J Neuroinflammation. 2014;11:13.

[56] Stratoulias V, Venero JL, Tremblay MÈ, Joseph B. Microglial subtypes: diversity within the microglial community. EMBO J. 2019;38(17):e101997.

[57] Bolós M, Llorens-Martín M, Perea JR, et al. Absence of CX3CR1 impairs the internalization of Tau by microglia. Mol Neurodegener. 2017;12(1):59.

[58] Cho I, Kim JM, Kim EJ, et al. Orthopedic surgery-induced cognitive dysfunction is mediated by CX3CL1/R1 signaling. J Neuroinflammation. 2021;18(1):93.

[59] Xu J, Dong H, Qian Q, et al. Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation. Behav Brain Res. 2017;332:145-153.

[60] Sun L, Dong R, Xu X, Yang X, Peng M. Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity. J Neuroinflammation. 2017;14(1):138.

[61] VanDusen KW, Li YJ, Cai V, et al. Cerebrospinal fluid proteome changes in older non-cardiac surgical patients with postoperative cognitive dysfunction. J Alzheimer’s Dis. 2021;80(3):1281-1297.

[62] Sun H, Li A, Hou T, et al. Neurogenesis promoted by the CD200/CD200R signaling pathway following treadmill exercise enhances post-stroke functional recovery in rats. Brain Behav Immun. 2019;82:354-371.

[63] Tammaro A, Derive M, Gibot S, Leemans JC, Florquin S, Dessing MC. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Pharmacol Ther. 2017;177:81-95.

[64] Xu P, Zhang X, Liu Q, et al. Microglial TREM1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke. Cell Death Dis. 2019;10(8):555-572.

[65] Jiang T, Zhang YD, Gao Q, et al. TREM1 facilitates microglial phagocytosis of amyloid beta. Acta Neuropathol. 2016;132(5):667-683.

[66] Xu P, Hong Y, Xie Y, et al. TREM1 exacerbates neuroinflammatory injury via NLRP3 inflammasome-mediated pyroptosis in experimental subarachnoid hemorrhage. Transl Stroke Res. 2020;12(4):643-659.

[67] Wu X, Zeng H, Xu C, et al. TREM1 regulates neuroinflammatory injury by modulate pro-inflammatory subtype transition of microglia and formation of neutrophil extracellular traps via interaction with SYK in experimental subarachnoid hemorrhage. Front Immunol. 2021;12:766178.

[68] Liang YB, Song PP, Zhu YH, et al. TREM1-targeting LP17 attenuates cerebral ischemia-induced neuronal injury by inhibiting oxidative stress and pyroptosis. Biochem Biophys Res Commun. 2020;529(3):554-561.

[69] Natale G, Biagioni F, Busceti CL, Gambardella S, Limanaqi F, Fornai F. TREM receptors connecting bowel inflammation to neurodegenerative disorders. Cells. 2019;8(10):1124-1144.

[70] Zhang JL, Wang B, Sun XP, Wang MS, Xun XN, Bi YL. The relationship between myeloid cell trigger receptors and postoperative cognitive dysfunction in elderly patients. Chin J Anesthesiol. 2018;38(12):1421-1425.

[71] Chen C, Gao R, Li M, et al. Extracellular RNAs-TLR3 signaling contributes to cognitive decline in a mouse model of postoperative cognitive dysfunction. Brain Behav Immun. 2019;80:439-451.

[72] Wang J, Xin Y, Chu T, Liu C, Xu A. Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1/RAGE/NF-Κb signaling pathway. Biomed Pharmacother. 2022;150:113006.

[73] Starossom SC, Mascanfroni ID, Imitola J, et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity. 2012;37(2):249-263.

[74] Shen Z, Xu H, Song W, et al. Galectin-1 ameliorates perioperative neurocognitive disorders in aged mice. CNS Neurosci Ther. 2021;27(7):842-856.

[75] Mostacada K, Oliveira FL, Villa-Verde DMS, Martinez AMB. Lack of galectin-3 improves the functional outcome and tissue sparing by modulating inflammatory response after a compressive spinal cord injury. Exp Neurol. 2015;271:390-400.

[76] Shen YF, Yu WH, Dong XQ, et al. The change of plasma galectin-3 concentrations after traumatic brain injury. Clin Chim Acta. 2016;456:75-80.

[77] Shan R, Szmydynger-Chodobska J, Warren OU, Mohammad F, Zink BJ, Chodobski A. A new panel of blood biomarkers for the diagnosis of mild traumatic brain injury/concussion in adults. J Neurotrauma. 2016;33:49-57.

[78] Bonsack F, Sukumari-Ramesh S. Differential cellular expression of galectin-1 and galectin-3 after intracerebral hemorrhage. Front Cell Neurosci. 2019;13:157.

[79] Yan YP, Lang BT, Vemuganti R, Dempsey RJ. Galectin-3 mediates post-ischemic tissue remodeling. Brain Res. 2009;1288:116-124.

[80] Silverstein RL, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signaling. 2009;2(72):re3.

[81] Grajchen E, Wouters E, van de Haterd B, et al. CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammation. J Neuroinflammation. 2020;17(1):224.

[82] Doens D, Valiente PA, Mfuh AM, et al. Identification of inhibitors of CD36-amyloid beta binding as potential agents for Alzheimer’s disease. ACS Chem Neurosci. 2017;8(6):1232-1241.

[83] Wilkinson K, Boyd JD, Glicksman M, Moore KJ, El Khoury J. A high content drug screen identifies ursolic acid as an inhibitor of amyloid βprotein interactions with its receptor CD36. J Biol Chem. 2011;286:34914-34922.

[84] Kim SM, Mun BR, Lee SJ, et al. TREM2 promotes Aβphagocytosis by upregulating C/EBPα-dependent CD36 expression in microglia. Sci Rep. 2017;7:11118.

[85] Castellano B, Queralt MB, Almolda B, Villacampa N, González B. Purine signaling and microglial wrapping. Adv Exp Med Biol. 2016;949:147-165.

[86] Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, Lamb BT. Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 2010;68:19-31.

[87] Rogers JT, Morganti JM, Bachstetter AD, et al. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci. 2011;31:16241-16250.

[88] Chen YN, Sha HH, Wang YW, et al. Histamine 2/3 receptor agonists alleviate perioperative neurocognitive disorders by inhibiting microglia activation through the PI3K/AKT/FoxO1 pathway in aged rats. J Neuroinflammation. 2020;17(1):217.

RIGHTS & PERMISSIONS

2023 The Authors. Ibrain published by Affiliated Hospital of Zunyi Medical University (AHZMU) and Wiley-VCH GmbH.